US2007259839A1PendingUtilityA1

Triterpene quaternary salts as biologically active surfactants

Assignee: UNIV MINNESOTAPriority: Jan 18, 2002Filed: Jun 19, 2007Published: Nov 8, 2007
Est. expiryJan 18, 2022(expired)· nominal 20-yr term from priority
A61P 31/10A61P 31/04C07J 53/00C07J 63/008C07J 63/00
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides novel compounds that are quaternary amine derivatives of betulin and other triterpenes. The compounds have antibacterial, antifungal, and surfactant properties.

Claims

exact text as granted — not AI-modified
1 - 115 . (canceled)  
     
     
         116 . A compound of formula (II):  
       
         
           
           
               
               
           
         
       
       wherein, 
 R 1  is absent or alkylene;  
 R 2  is hydrogen, N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ;  
 R 3  is absent, or oxy;  
 R 4  is absent or alkylene;  
 R 5  is hydrogen, N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ;  
 R 6  is absent, oxy, thio, or imino;  
 R 7  is absent or alkylene;  
 R 8  is hydrogen, N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ;  
 R a , R b , and R c  are each independently (C 1 -C 24 )alkyl, aryl, arylalkyl, heteroarylalkly, heterocycle, or heterocylealkyl;  
 any heteroaryl, heterocycle, or R a , R b , or R c  of R 2 , R 5 , and R 8  can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —NR d R e , or cycloalkylalkyl;  
 R d  and R e  are each independently hydrogen or alkyl;  
 any alkyl or alkylene of R 1 , R 2 , R 4 , R 5 , R 7 , or R 8  can be optionally substituted on carbon with one or more oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and is optionally partially unsaturated;  
 or an acceptable salt thereof.  
 
     
     
         117 . The compound of  claim 116 , wherein N + -containing heteroaryl is N-pyridinium, N-methyl-2-pyridinium, N-methyl-3-pyridinium, N-methyl-4-pyridinium, N-ethyl-2-pyridinium, N-ethyl-3-pyridinium, N-ethylpyridinium, 3,5-dimethylpyridinium, or 4-(dimethylamino)pyridinium; 
 wherein any heteroaryl can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —NR d R e , or cycloalkylalkyl;    wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         118 . The compound of  claim 116 , wherein N + -containing heterocycle is N-diazabicyclo[2.2.2]octyl; N-azabicyclo[2.2.2]octyl; N-methyl-N-piperidino; N,N-dimethyl-2-piperidino; N,N-dimethyl-3-piperidino; N,N-dimethyl-4-piperidino; N-methyl-N-morpholino; N,N-dimethyl-2-morpholino; or N,N-dimethyl-3-morpholino; 
 wherein any heterocycle can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —NR d R e , or cycloalkylalkyl;    wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         119 . The compound of  claim 116 , wherein —N + —R a R b R c  is N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N,N,N′,N′-tetramethylethylenediamine-N-yl; octyldimethylammonium; tetradecyldimethylammonium; trimethylammonium; triethylammonium, or tri(hydroxymethyl)ammonium.  
     
     
         120 . The compound of  claim 116 , wherein R 2 , R 5 , and R 8  are each independently absent, hydroxyl, N-diazabicyclo[2.2.2]octyl, N-pyridinium, N-alkyl-N-piperidino, N-alkyl-N-morpholino, N-azabicyclo[2.2.2]octyl, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; 
 wherein N-diazabicyclo[2.2.2]octyl; N-pyridinium; N-alkyl-N-piperidino; N-alkyl-N-morpholino; and N-azabicyclo[2.2.2]octyl can optionally be substituted on one or more suitable carbon atoms with one or more oxo, hydroxy, mercapto, alkyl, hydroxyalkyl, halo, nitro, cyano, (C 1 -C 6 )alkoxy, —COOR d , or —NR d R e ;    wherein any alkyl or alkylene of R 1 , R 2 , R 4 , R 5 , R 7 , or R 8  can optionally be substituted with one or more oxo or —NR d R e , and optionally interrupted with one or more oxy, imino, or thio, and can optionally be partially unsaturated;    wherein R d  and R e  are each independently hydrogen or alkyl    
     
     
         121 . The compound of  claim 116 , wherein R 1  is absent and R 2  is hydrogen, N-diazabicyclo[2.2.2]octyl, or N-dimethylamino-N-pyridinium.  
     
     
         122 . The compound of  claim 116 , wherein R 3  and R 4  are absent, and R 5  is hydrogen.  
     
     
         123 . The compound of  claim 116 , wherein R 3  is oxy; R 4  is absent or (C 1 -C 5 )alkylenecarbonyl; and R 5  is hydrogen, N-diazabicyclo[2.2.2]octyl; 4-dimethylamino-N-pyridinium; 4-hydroxybutyl-N-diazabicyclo[2.2.2]octyl; 4-benzyl-N-diazabicyclo[2.2.2]octyl; tetramethylethylenediamine-N-yl; N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N-pyridinium; 4-hydroxymethyl-N-pyridinium; 2,4-dimethyl-N-pyridinium; 3,5-dimethyl-N-pyridinium; octyldimethylammonium; or tetradecyldimethylammonium.  
     
     
         124 . The compound of  claim 116 , wherein R 6  is oxy; R 7  is absent or (C 1 -C 5 )alkylenecarbonyl; and R 8  is hydrogen, N-diazabicyclo[2.2.2]octyl; 4-dimethylamino-N-pyridinium; N′-(4-hydroxybutyl)-N-diazabicyclo[2.2.2]octyl; N′-benzyl-N-diazabicyclo[2.2.2]octyl; N,N,N′,N′-tetramethylethylenediamine-N-yl; N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N-pyridinium; 4-hydroxymethyl-N-pyridinium; 2,4-dimethyl-N-pyridinium; 3,5-dimethyl-N-pyridinium; octyldimethylammonium; tetradecyldimethylammonium; 2-methyl-N-pyridinium; 4-hydroxy-N-methyl-N-piperidinium; or N-methyl-N-morpholino.  
     
     
         125 . The compound of  claim 116 , wherein at least one of R 2 , R 5 , and R 8  is —N + R a R b R c  wherein R a  and R b  are each independently (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; wherein R d  and R e  are each independently hydrogen or alkyl.  
     
     
         126 . The compound of  claim 125 , wherein R 1  is absent and R 2  is hydrogen.  
     
     
         127 . The compound of  claim 116 , wherein at least one of R 2 , R 5 , and R 8  is —N + R a R b R c  wherein R a  and R b  are each independently (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; wherein R d  and R e  are each independently hydrogen or alkyl; 
 R 1  is absent and    R 2  is hydrogen.    
     
     
         128 . The compound of  claim 116 , wherein R 6  is oxy, R 7  is absent, and R 8  is hydrogen.  
     
     
         129 . The compound of  claim 116 , wherein the R 4  is acetyl.  
     
     
         130 . The compound of  claim 116 , wherein R 5  is —N + R a R b R c , wherein R a  and R b  are each (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; 
 wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         131 . The compound of  claim 116 , wherein R 5  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl.  
     
     
         132 . The compound of  claim 116 , wherein R 4  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R d  is (C 1 -C 24 )alkyl.  
     
     
         133 . The compound of  claim 116 , wherein R 5  is —N + R a R b R d  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R c  is (C 1 -C 6 )alkyl.  
     
     
         134 . The compound of  claim 116 , wherein R 6  is absent, or oxy.  
     
     
         135 . The compound of  claim 116 , wherein R 7  is acetyl.  
     
     
         136 . The compound of  claim 116 , wherein R 8  is —N + R a R b R d , wherein R a  and R b  are each (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; 
 wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         137 . The compound of  claim 116 , wherein the R 8  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl.  
     
     
         138 . The compound of  claim 116 , wherein the R 8  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R c  is (C 1 -C 6 )alkyl.  
     
     
         139 . A compound of formula (II):  
       
         
           
           
               
               
           
         
       
       wherein, 
 R 1  is absent or alkylene;  
 R 2  is hydrogen, N + -containing heteroaryl, N′-containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ;  
 R 3  is absent, oxy, thio, or imino;  
 R 4  is absent or alkylene;  
 R 5  is hydrogen, N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N-containing heterocycle, or —N + R a R b R c ;  
 R 6  is absent, or oxy;  
 R 7  is absent or alkylene;  
 R 8  is hydrogen, N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ;  
 R a , R b , and R c  are each independently (C 1 -C 24 )alkyl, aryl, arylalkyl, heteroarylalkly, heterocycle, or heterocylealkyl;  
 any heteroaryl, heterocycle, or R a , R b , or R c  of R 2 , R 5 , and R 8  can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —NR d R e , or cycloalkylalkyl;  
 R d  and R e  are each independently hydrogen or alkyl;  
 any alkyl or alkylene of R 1 , R 2 , R 4 , R 5 , R 7 , or R 8  can be optionally substituted on carbon with one or more oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and is optionally partially unsaturated;  
 or an acceptable salt thereof.  
 
     
     
         140 . The compound of  claim 139 , wherein N + -containing heteroaryl is N-pyridinium, N-methyl-2-pyridinium, N-methyl-3-pyridinium, N-methylpyridinium, N-ethyl-2-pyridinium, N-ethyl-3-pyridinium, N-ethylpyridinium, 3,5-dimethylpyridinium, or 4-(dimethylamino)pyridinium; 
 wherein any heteroaryl can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —N d R e , or cycloalkylalkyl;    wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         141 . The compound of  claim 139 , wherein N + -containing heterocycle is N-diazabicyclo[2.2.2]octyl; N-azabicyclo[2.2.2]octyl; N-methyl-N-piperidino; N,N-dimethyl-2-piperidino; N,N-dimethyl-3-piperidino; N,N-dimethylpiperidino; N-methyl-N-morpholino; N,N-dimethyl-2-morpholino; or N,N-dimethyl-3-morpholino; 
 wherein any heterocycle can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —NR d R e , or cycloalkylalkyl;    wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         142 . The compound of  claim 139 , wherein —N + R a R b R c  is N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N,N,N′,N′-tetramethylethylenediamine-N-yl; octyldimethylammonium; tetradecyldimethylammonium; trimethylammonium; triethylammonium, or tri(hydroxymethyl)ammonium.  
     
     
         143 . The compound of  claim 139 , wherein R 2 , R 5 , and R 8  are each independently absent, hydroxyl, N-diazabicyclo[2.2.2]octyl, N-pyridinium, N-alkyl-N-piperidino, N-alkyl-N-morpholino, N-azabicyclo[2.2.2]octyl, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; 
 wherein N-diazabicyclo[2.2.2]octyl; N-pyridinium; N-alkyl-N-piperidino; N-alkyl-N-morpholino; and N-azabicyclo[2.2.2]octyl can optionally be substituted on one or more suitable carbon atoms with one or more oxo, hydroxy, mercapto, alkyl, hydroxyalkyl, halo, nitro, cyano, (C 1 -C 6 )alkoxy, —COOR d , or —NR d R e ;    wherein any alkyl or alkylene of R 1 , R 2 , R 4 , R 5 , R 7 , or R 8  can optionally be substituted with one or more oxo or —NR d R e , and optionally interrupted with one or more oxy, imino, or thio, and can optionally be partially unsaturated;    wherein R d  and R e  are each independently hydrogen or alkyl    
     
     
         144 . The compound of  claim 139 , wherein R 1  is absent and R 2  is hydrogen, N-diazabicyclo[2.2.2]octyl, or N-dimethylamino-N-pyridinium.  
     
     
         145 . The compound of  claim 139 , wherein R 3  and R 4  are absent, and R 5  is hydrogen.  
     
     
         146 . The compound of  claim 139 , wherein R 3  is oxy; R 4  is absent or (C 1 -C 5 )alkylenecarbonyl; and R 5  is hydrogen, N-diazabicyclo[2.2.2]octyl; 4-dimethylamino-N-pyridinium; 4-hydroxybutyl-N-diazabicyclo[2.2.2]octyl; 4-benzyl-N-diazabicyclo[2.2.2]octyl; tetramethylethylenediamine-N-yl; N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N-pyridinium; 4-hydroxymethyl-N-pyridinium; 2,4-dimethyl-N-pyridinium; 3,5-dimethyl-N-pyridinium; octyldimethylammonium; or tetradecyldimethylammonium.  
     
     
         147 . The compound of  claim 139 , wherein R 6  is oxy; R 7  is absent or (C 1 -C 5 )alkylenecarbonyl; and R 8  is hydrogen, N-diazabicyclo[2.2.2]octyl; 4-dimethylamino-N-pyridinium; N′-(4-hydroxybutyl)-N-diazabicyclo[2.2.2]octyl; N′-benzyl-N-diazabicyclo[2.2.2]octyl; N,N,N′,N′-tetramethylethylenediamine-N-yl; N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N-pyridinium; 4-hydroxymethyl-N-pyridinium; 2,4-dimethyl-N-pyridinium; 3,5-dimethyl-N-pyridinium; octyldimethylammonium; tetradecyldimethylammonium; 2-methyl-N-pyridinium; 4-hydroxy-N-methyl-N-piperidinium; or N-methyl-N-morpholino.  
     
     
         148 . The compound of  claim 139 , wherein at least one of R 2 , R 5 , and R 8  is —N + R a R b R c  wherein R a  and R b  are each independently (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; wherein R d  and R e  are each independently hydrogen or alkyl.  
     
     
         149 . The compound of  claim 148 , wherein R 1  is absent and R 2  is hydrogen.  
     
     
         150 . The compound of  claim 149 , wherein 
 R 3  is absent or oxy, R 4  is absent, R 5  is hydrogen; or    R 6  is oxy, R 7  is absent, and R 8  is hydrogen.    
     
     
         151 . The compound of  claim 139 , wherein at least one of R 2 , R 5 , and R 8  is —N + R a R b R c  wherein R a  and R b  are each independently (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR a , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; wherein R d  and R e  are each independently hydrogen or alkyl; 
 R 1  is absent and    R 2  is hydrogen.    
     
     
         152 . The compound of  claim 139 , wherein the at least one of R 2 , R 5 , and R 8  is —N + R a R b R a  wherein R a  and R b  are each independently (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R a , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; wherein R d  and R e  are each independently hydrogen or alkyl; 
 R 1  is absent and    R 2  is hydrogen,    R 3  is absent or oxy,    R 4  is absent, and    R 5  is hydrogen.    
     
     
         153 . The compound of  claim 139 , wherein R 6  is oxy, R 7  is absent, and R 8  is hydrogen.  
     
     
         154 . The compound of  claim 139 , wherein R 3  is absent, or oxy.  
     
     
         155 . The compound of  claim 139 , wherein the R 4  is acetyl.  
     
     
         156 . The compound of  claim 139 , wherein R 5  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; 
 wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         157 . The compound of  claim 139 , wherein R 5  is —NR a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl.  
     
     
         158 . The compound of  claim 139 , wherein R 4  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R e  is (C 1 -C 24 )alkyl.  
     
     
         159 . The compound of  claim 139 , wherein R 5  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R c  is (C 1 -C 6 )alkyl.  
     
     
         160 . The compound of  claim 139 , wherein R 7  is acetyl.  
     
     
         161 . The compound of  claim 139 , wherein R 8  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; 
 wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         162 . The compound of  claim 139 , wherein the R 8  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl.  
     
     
         163 . The compound of  claim 139 , wherein the R 8  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R e  is (C 1 -C 6 )alkyl.  
     
     
         164 . A compound of formula (II):  
       
         
           
           
               
               
           
         
       
       wherein, 
 R 1  is absent or alkylene;  
 R 2  is hydrogen, N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ;  
 R 3  is absent, or oxy;  
 R 4  is absent or alkylene;  
 R 5  is hydrogen, N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ;  
 R 6  is absent, or oxy;  
 R 7  is absent or alkylene;  
 R 8  is hydrogen, N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ;  
 R a , R b , and R c  are each independently (C 1 -C 24 )alkyl, aryl, arylalkyl, heteroarylalkly, heterocycle, or heterocylealkyl;  
 any heteroaryl, heterocycle, or R a , R b , or R c  of R 2 , R 5 , and R 8  can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —NR d R e , or cycloalkylalkyl;  
 R d  and R e  are each independently hydrogen or alkyl;  
 any alkyl or alkylene of R 1 , R 2 , R 4 , R 5 , R 7 , or R 8  can be optionally substituted on carbon with one or more oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and is optionally partially unsaturated;  
 or an acceptable salt thereof.  
 
     
     
         165 . The compound of  claim 164 , wherein N + -containing heteroaryl is N-pyridinium, N-methyl-2-pyridinium, N-methyl-3-pyridinium, N-methyl-4-pyridinium, N-ethyl-2-pyridinium, N-ethyl-3-pyridinium, N-ethyl-4-pyridinium, 3,5-dimethylpyridinium, or 4-(dimethylamino)pyridinium; 
 wherein any heteroaryl can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —NR d R e , or cycloalkylalkyl;    wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         166 . The compound of  claim 164 , wherein N + -containing heterocycle is N-diazabicyclo[2.2.2]octyl; N-azabicyclo[2.2.2]octyl; N-methyl-N-piperidino; N,N-dimethyl-2-piperidino; N,N-dimethyl-3-piperidino; N,N-dimethylpiperidino; N-methyl-N-morpholino; N,N-dimethyl-2-morpholino; or N,N-dimethyl-3-morpholino; 
 wherein any heterocycle can optionally be substituted on carbon with one or more alkyl, hydroxyalkyl, arylalkyl, heteroarylalkyl, aryl, heterocycle, heterocyclealkyl, oxo, hydroxy, halo, nitro, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , —NR d R e , or cycloalkylalkyl;    wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         167 . The compound of  claim 164 , wherein —N + —R a R b R c  is N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N,N,N′,N′-tetramethylethylenediamine-N-yl; octyldimethylammonium; tetradecyldimethylammonium; trimethylammonium; triethylammonium, or tri(hydroxymethyl)ammonium.  
     
     
         168 . The compound of  claim 164 , wherein R 2 , R 5 , and R 8  are each independently absent, hydroxyl, N-diazabicyclo[2.2.2]octyl, N-pyridinium, N-alkyl-N-piperidino, N-alkyl-N-morpholino, N-azabicyclo[2.2.2]octyl, or —N + R a R b R c ; provided at least one of R 2 , R 5 , and R 8  is N + -containing heteroaryl, N + -containing heterocycle, or —N + R a R b R c ; 
 wherein N-diazabicyclo[2.2.2]octyl; N-pyridinium; N-alkyl-N-piperidino; N-alkyl-N-morpholino; and N-azabicyclo[2.2.2]octyl can optionally be substituted on one or more suitable carbon atoms with one or more oxo, hydroxy, mercapto, alkyl, hydroxyalkyl, halo, nitro, cyano, (C 1 -C 6 )alkoxy, —COOR d , or —NR d R e ;    wherein any alkyl or alkylene of R 1 , R 2 , R 4 , R 5 , R 7 , or R 8  can optionally be substituted with one or more oxo or —NR d R e , and optionally interrupted with one or more oxy, imino, or thio, and can optionally be partially unsaturated;    wherein R d  and R e  are each independently hydrogen or alkyl    
     
     
         169 . The compound of  claim 164 , wherein R 1  is absent and R 2  is hydrogen, N-diazabicyclo[2.2.2]octyl, or N-dimethylamino-N-pyridinium.  
     
     
         170 . The compound of  claim 164 , wherein R 3  and R 4  are absent, and R 5  is hydrogen.  
     
     
         171 . The compound of  claim 164 , wherein R 3  is oxy; R 4  is absent or (C 1 -C 5 )alkylenecarbonyl; and R 5  is hydrogen, N-diazabicyclo[2.2.2]octyl; 4-dimethylamino-N-pyridinium; 4-hydroxybutyl-N-diazabicyclo[2.2.2]octyl; 4-benzyl-N-diazabicyclo[2.2.2]octyl; tetramethylethylenediamine-N-yl; N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N-pyridinium; 4-hydroxymethyl-N-pyridinium; 2,4-dimethyl-N-pyridinium; 3,5-dimethyl-N-pyridinium; octyldimethylammonium; or tetradecyldimethylammonium.  
     
     
         172 . The compound of  claim 164 , wherein R 6  is oxy; R 7  is absent or (C 1 -C 5 )alkylenecarbonyl; and R 8  is hydrogen, N-diazabicyclo[2.2.2]octyl; 4-dimethylamino-N-pyridinium; N′-(4-hydroxybutyl)-N-diazabicyclo[2.2.2]octyl; N′-benzyl-N-diazabicyclo[2.2.2]octyl; N,N,N′,N′-tetramethylethylenediamine-N-yl; N′-benzyl-N,N,N′,N′-tetramethylethylenediamine-N-yl; N-pyridinium; 4-hydroxymethyl-N-pyridinium; 2,4-dimethyl-N-pyridinium; 3,5-dimethyl-N-pyridinium; octyldimethylammonium; tetradecyldimethylammonium; 2-methyl-N-pyridinium; 4-hydroxy-N-methyl-N-piperidinium; or N-methyl-N-morpholino.  
     
     
         173 . The compound of  claim 164 , wherein at least one of R 2 , R 5 , and R 8  is —N + R a R b R c  wherein R a  and R b  are each independently (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; wherein R d  and R e  are each independently hydrogen or alkyl.  
     
     
         174 . The compound of  claim 173 , wherein R 1  is absent and R 2  is hydrogen.  
     
     
         175 . The compound of  claim 164 , wherein at least one of R 2 , R 5 , and R 8  is —N + R a R b R c  wherein R a  and R b  are each independently (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; wherein R d  and R e  are each independently hydrogen or alkyl; 
 R 1  is absent and    R 2  is hydrogen.    
     
     
         176 . The compound of  claim 164 , wherein R 6  is oxy, R 7  is absent, and R 8  is hydrogen.  
     
     
         177 . The compound of  claim 164 , wherein the R 4  is acetyl.  
     
     
         178 . The compound of  claim 164 , wherein R 5  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; 
 wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         179 . The compound of  claim 164 , wherein R 5  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl.  
     
     
         180 . The compound of  claim 164 , wherein R 4  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R c  is (C 1 -C 24 )alkyl.  
     
     
         181 . The compound of  claim 164 , wherein R 5  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R c  is (C 1 -C 6 )alkyl.  
     
     
         182 . The compound of  claim 164 , wherein R 7  is acetyl.  
     
     
         183 . The compound of  claim 164 , wherein R 8  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl optionally substituted on carbon with one or more oxo, hydroxy, halo, cyano, (C 1 -C 6 )alkoxy, trifluoromethyl, —COOR d , or —NR d R e , and optionally interrupted on carbon with one or more oxy, imino, or thio, and optionally partially unsaturated; 
 wherein R d  and R e  are each independently hydrogen or alkyl.    
     
     
         184 . The compound of  claim 164 , wherein the R 8  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl.  
     
     
         185 . The compound of  claim 164 , wherein the R 8  is —N + R a R b R c  wherein R a  and R b  are each (C 6 -C 24 )alkyl and R c  is (C 1 -C 6 )alkyl.  
     
     
         186 . A pharmaceutical composition comprising a pharmaceutically effective diluent or carrier, and a compound of any one of claims  116 ,  139  and  164 .  
     
     
         187 . A method of inhibiting or killing a fungus, the method comprising contacting the fungus with an effective anti-fungal amount of a compound of any one of claims  116 ,  139  and  164 .  
     
     
         188 . A method of inhibiting or killing a bacterium, the method comprising contacting the bacterium with an effective anti-bacterial amount of a compound of any one of claims  116 ,  139  and  164 .

Join the waitlist — get patent alerts

Track US2007259839A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.